Carl Zeiss Meditec AG (OTCMKTS:CZMWY – Get Free Report) was the recipient of a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 1,300 shares, a drop of 35.0% from the February 13th total of 2,000 shares. Based on an average trading volume of 13,600 shares, the short-interest ratio is presently 0.1 days.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group upgraded Carl Zeiss Meditec from a “sell” rating to a “buy” rating in a research note on Tuesday, March 11th.
Read Our Latest Stock Report on CZMWY
Carl Zeiss Meditec Price Performance
Carl Zeiss Meditec Announces Dividend
The company also recently declared an annual dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.6246 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a dividend yield of 1%. Carl Zeiss Meditec’s dividend payout ratio is currently 32.64%.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Further Reading
- Five stocks we like better than Carl Zeiss Meditec
- How to Read Stock Charts for Beginners
- How to Build the Ultimate Everything ETF Portfolio
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.